Adial Pharmaceuticals, Inc. (ADIL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Adial Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.46x | -1.42x | -0.38x | -0.46x | -2.58x | -1.95x |
| P/B Ratio | 0.70x | 4.62x | 0.65x | 1.78x | 14.31x | 5.32x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 4.42x | 4.16x | 4.90x | 2.67x | 2.37x | 3.41x |
| Quick Ratio | 4.42x | 4.16x | 4.90x | 2.67x | 2.37x | 3.41x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.06x | 0.07x | 0.00x |
YoY = year-over-year change. Source: FMP..